Sientra Inc. expected to be the queen of the breast-implant industry when it entered the U.S. market in 2012 with set of new shapes and textures – so much for women to choose from. Said so, the company was supplying about 9-10 percent of implants in the U.S., a.k.a. took roughly $30 million of $300 million […]
Rare Element Resources (REE) shares gained 20.86% on Friday’s trading session closed a few cents off of its monthly resistance within 4X 3month volume average: Classical chart setup, isn’t it? Rare Element Resources Ltd. is a mineral resource company focused on exploration and development of rare earth deposits, specifically those with significant distribution of critical […]
GlassesOff (GLSO) could revolutionize how presbyopia is treated, all for 15 minutes a day, 3 days a week, for 2 – 3 months at most. Decades of research into neuroplasticity underlie a robust program that is developed as a ‘game’ that ‘trains’ your brain to better process near objects and images. GLSO recently announced the […]
We sent email to our subscribers on August 29th with our new break-out pick: Advaxis (ADXS). Congratulations to all who followed our alert – ADXS‘s share price doubled in less than 2 weeks! Email: ADXS Breaks Resistance and Set To Rally Advaxis made a strong move on Thursday, despite the typical quiet week of trading before […]
Antriabio – which trades under the ticker “ANTB” – is about to bounce. If you’ve been following what I have to say I also think ANTB has 10-bagger potential (more about that in a moment). According to otcshortreport.com, about 50% of the shares that have traded in the last 30 days were sold short. A […]
ARCA Biopharma (ABIO) has been alerted as day-trading investment opportunity in real-time to our Twitter & Facebook followers at an around $.50/share. ABIO stock closed at $.68/share for the solid 36% in day-trading gains. Yesterday ABIO announced an update on a proposed, genetically-targeted clinical trial in atrial fibrillation (“AF”) of the Company’s lead developmental drug, Gencaro […]
edited on 02/02/2013: AntriaBio, Inc. (“AntriaBio”) announced that FINRA has approved a change of the Company’s stock ticker symbol. Effective today, the Company’s common shares will commence trading on the OTC Bulletin Board under the trading symbol “ANTB” ( OTCQB : ANTB ). The previous trading symbol was “FMYY” ( OTCQB : FMYY ). AntriaBio, […]
Implant Sciences develops and manufactures explosive trace detection sensors and systems that are capable of detecting minute amounts of a wide variety of military, commercial, and homemade explosives. IMSC’s patented technologies provide unique screening capabilities to extend and improve counter-terrorist and homeland security efforts. Read our due diligence report from the last year here. Yesterday, […]
Zoom Technologies (ZOOM) has been alerted on Twitter, as a trading opportunity, after company’s announcement of the execution of a definitive agreement pursuant to which it will sell its China-based manufacturing, sales and marketing, and R&D subsidiaries, and that the proceeds of the sale will be used for the purchase of additional U.S.-based businesses. Zoom […]
Catalyst Pharmaceutical Partners (NASDAQ: CPRX) stock found a bottom after sell-off (tax-losses) in the mid-December 2012 and now offers a solid trading opportunity. Besides technical analysis, there are more reasons to join this trade: CPRX announced on December 27th that it received a Nasdaq Staff Deficiency Letter for not compliance with the Minimum Bid Price requirement ($1/share) […]
